DKSH reported RM13.4m profit in 4Q16, +32.6% yoy & +146.2% qoq. This brings its full year 2016 profit to RM50.5m, +37% yoy. If we adjust the one-off impairment on receivables of rm15m in 2016, the full year core profit +70% yoy, translating to a record core profit of RM62m (13.4x FY16 PE). Since its inception, DKSH has never record core profit of more than RM60m p.a. This is literally a record year for the co!
As I expected, operating cash flow return to positive and the co closed the account with RM42.9m net cash as at FY16. I think this helps to clear the air as some investors were worry about the "deteriorating" cash flow in 3Q16.
Management's tone on 2017 outlook is upbeat vs cautious view on 2016 when IR reported its 4Q15 results last year. Organic growth for the revenue was at high single digit in 2016, after adjusting for the impact of change of clientele for telco prepaid card.
Going forward, the co is expected to continue to grow its revenue at mid to high single digit, while profit is expected to grow at 3x of its top line growth as I explained in my first article earlier. Assuming 20% core profit growth in 2017, DKSH is trading at 11x FY17 PE, or 8.2x PE if you exclude the net cash and net working capital (RM457m) as at FY16.
Again, for a distributor of healthcare and fmcg products, net working capital is as good as cash and that serves as a basis for the high teens PE multiples that most of the dominant distributor trading at, including DKSH Swiss which is trading at 20x fy17 PE.
By valuing the co at 17x FY17, the fair value would be RM8.00, translating to 52% upside from the current price.
Not much growth potential going forward. They have just lost two major customers. Although DKSH current assets are very liquid and as good as cash as what sumato claimed, investors will always look at the EPS first.
Hi Flintstones - which two clients have they lost? They have deliberately dropped a telecommunications client that was dragging down profits. Whilst negative for 2016, this is a positive development for 2017.
Not much growth potential already. Weakening ringgit will cut margin going forward. Petrol price already shoot up 21% this year! Oil price go up more is very bad for DKSH. Potential to suffer loss this year. Target price is RM 3!
Not much growth potential already. Weakening ringgit will cut margin going forward. Petrol price already shoot up 21% this year! Oil price go up more is very bad for DKSH. Potential to suffer loss this year. Target price is RM 3!
@Sumato88, I believe in you... hahahaha at this rate, I am so tempted to continue to sapu somemore DKSH as fixed deposit. hahahahaha.....
RM8.... I think you may have conservatively slightly undervaluing DKSH, I think u should value it at 20x like its parent in Swiss which is at RM9.4, since we are in a developing country and there are more room for growth, and as more manufacturing company is moving to specialization, definitely they will be needing DKSH's B2C or B2B outsourcing services. (this is assuming there are no other shocks like impairment of receivables or inventories anymore in future.)
I always like this kind of stock that gives transparent and honest earnings rather than other goreng-goreng stock, if the honesty and integrity continue, hopefully one day it be like PETDAG or Public Bank.... fly to RM23 or 24 ( Just my dreams)......
poor results yet 5.00.....likely cannot down much due to low liquidity.but if didn't down much,if will gradually slow slow down.better avoid this stock until next quarter
Any reason remove DKSH from syariah list. With annual turnover 5-6bil,and constant dividend 8-9 cent per year,i wont believe fund manager wil sell this counter.only those Sohai who dont know investment will keep on selling this counter. PE 8 means within 8 years time,you can get back your investment. Think yourself before invest.
no reason was mentioned, could be the products they distribute non Halal, could be the loans structure not comply to syariah, etc.... This counter has very low liquity , so there is a possibility of some syariah compliance funds are forced to sell (just my personal opinion, not really sure how those funds work).
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
sumato88
42 posts
Posted by sumato88 > 2017-02-22 01:22 | Report Abuse
DKSH reported RM13.4m profit in 4Q16, +32.6% yoy & +146.2% qoq. This brings its full year 2016 profit to RM50.5m, +37% yoy. If we adjust the one-off impairment on receivables of rm15m in 2016, the full year core profit +70% yoy, translating to a record core profit of RM62m (13.4x FY16 PE). Since its inception, DKSH has never record core profit of more than RM60m p.a. This is literally a record year for the co!
As I expected, operating cash flow return to positive and the co closed the account with RM42.9m net cash as at FY16. I think this helps to clear the air as some investors were worry about the "deteriorating" cash flow in 3Q16.
Management's tone on 2017 outlook is upbeat vs cautious view on 2016 when IR reported its 4Q15 results last year. Organic growth for the revenue was at high single digit in 2016, after adjusting for the impact of change of clientele for telco prepaid card.
Going forward, the co is expected to continue to grow its revenue at mid to high single digit, while profit is expected to grow at 3x of its top line growth as I explained in my first article earlier. Assuming 20% core profit growth in 2017, DKSH is trading at 11x FY17 PE, or 8.2x PE if you exclude the net cash and net working capital (RM457m) as at FY16.
Again, for a distributor of healthcare and fmcg products, net working capital is as good as cash and that serves as a basis for the high teens PE multiples that most of the dominant distributor trading at, including DKSH Swiss which is trading at 20x fy17 PE.
By valuing the co at 17x FY17, the fair value would be RM8.00, translating to 52% upside from the current price.
I am happy with the performance indeed.